- Patent Title: SIRPalpha-4-1BBL variant fusion protein and methods of use thereof
-
Application No.: US17258170Application Date: 2019-07-11
-
Publication No.: US12134638B2Publication Date: 2024-11-05
- Inventor: Iris Pecker , Itai Bloch
- Applicant: KAHR Medical Ltd.
- Applicant Address: IL Jerusalem
- Assignee: KAHR Medical Ltd.
- Current Assignee: KAHR Medical Ltd.
- Current Assignee Address: IL Jerusalem
- International Application: PCT/IL2019/050783 WO 20190711
- International Announcement: WO2020/012486 WO 20200116
- Main IPC: C07K14/705
- IPC: C07K14/705 ; A61K38/00 ; A61P35/00 ; A61K39/00
Abstract:
SIRPalpha-4-1BBL variant fusion proteins are provided. Also provided are isolated polypeptides comprising a SIRPalpha variant. Also provided are polynucleotides and nucleic acid constructs encoding the SIRPalpha-41BBL fusion protein or the isolated polypeptide, host-cells expressing same and methods of use thereof.
Public/Granted literature
- US20210214417A1 SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF Public/Granted day:2021-07-15
Information query
